Primary cutaneous aspergillosis in an immunocompetent patient: successful treatment with oral voriconazole

Pediatr Dermatol. 2009 Jul-Aug;26(4):493-5. doi: 10.1111/j.1525-1470.2009.00971.x.

Abstract

We report a case of primary cutaneous aspergillosis in an immunocompetent child that responded rapidly to oral voriconazole therapy. Voriconazole may be considered as a treatment option for pediatric patients with primary cutaneous aspergillosis.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Antifungal Agents / administration & dosage*
  • Aspergillosis / drug therapy*
  • Aspergillosis / immunology*
  • Aspergillosis / pathology
  • Cicatrix / pathology
  • Dermatomycoses / drug therapy*
  • Dermatomycoses / immunology*
  • Dermatomycoses / pathology
  • Humans
  • Immunocompetence*
  • Infant
  • Male
  • Pyrimidines / administration & dosage*
  • Treatment Outcome
  • Triazoles / administration & dosage*
  • Voriconazole

Substances

  • Antifungal Agents
  • Pyrimidines
  • Triazoles
  • Voriconazole